CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine

被引：17
|
作者：
Capi, Matilde [1 ]
De Angelis, Valerio [2 ]
De Bernardini, Donatella [1 ]
De Luca, Ottavia [3 ]
Cipolla, Fabiola [2 ]
Lionetto, Luana [1 ]
Simmaco, Maurizio [1 ,3 ,4 ]
Martelletti, Paolo [2 ]
机构：
[1] St Andrea Univ Hosp, Mass Spectrometry Unit, Lab Clin Biochem, I-00185 Rome, Italy
[2] Sapienza Univ Rome, Dept Clin & Mol Med, I-00185 Rome, Italy
[3] St Andrea Univ Hosp, Adv Mol Diagnost Unit, Lab Clin Biochem, I-00185 Rome, Italy
[4] Sapienza Univ, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, I-00185 Rome, Italy
来源：
JOURNAL OF CLINICAL MEDICINE | 2021年 / 10卷 / 07期
关键词：
migraine; CGRP; therapy; gepants; ditans; antagonism; CGRP receptor; GENE-RELATED PEPTIDE; MONOCLONAL-ANTIBODIES; SAFETY PROFILE; LASMIDITAN;
D O I：
10.3390/jcm10071429
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Discovering that calcitonin-related peptide (CGRP) plays a key role in the complex pathophysiology of migraine has allowed us to make great strides in the development of new approaches for acute and preventive treatment. This evidence has led to the development of small molecules antagonist molecules of the CGRP receptor ("gepants") and of a new class of medications called "Ditans". This review presents the data from clinical trials reporting the efficacy, safety, and tolerability of the new drugs used in the treatment of migraines. Evidences show that therapeutic approaches targeted to CGRP have the potential to transform the clinical management of migraine, even though its appropriate place has yet to be determined with accuracy.
引用
收藏
页数：17
相关论文
共 50 条
  • [41] Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor
    Blumenfeld, Andrew
    Durham, Paul L.
    Feoktistov, Alexander
    Hay, Debbie L.
    Russo, Andrew F.
    Turner, Ira
    NEUROLOGY AND THERAPY, 2021, 10 (02) : 469 - 497
  • [42] Review of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonists
    Hougaard, Anders
    Tfelt-Hansen, Peer
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (09) : 1409 - 1418
  • [43] Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine
    Moore, Eric L.
    Salvatore, Christopher A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (01) : 66 - 78
  • [44] Novel Therapies in Acute Migraine Management: Small-Molecule Calcitonin Gene-Receptor Antagonists and Serotonin 1F Receptor Agonist
    Joyner, Kayla Rena
    Morgan, Kelsey Woods
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (06) : 745 - 759
  • [45] 5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs
    Johnson, KW
    Schaus, JM
    Durkin, MM
    Audia, JE
    Kaldor, SW
    Flaugh, ME
    Adham, N
    Zgombick, JM
    Cohen, ML
    Branchek, TA
    Phebus, LA
    NEUROREPORT, 1997, 8 (9-10) : 2237 - 2240
  • [46] Colocalization of 5-HT1F receptor and calcitonin gene-related peptide in rat vestibular nuclei
    Ahn, Seong-Ki
    Khalmuratova, Roza
    Jeon, Sea-Yuong
    Kim, Jin-Pyeong
    Park, Jung Je
    Hur, Dong Gu
    Balaban, Carey D.
    NEUROSCIENCE LETTERS, 2009, 465 (02) : 151 - 156
  • [47] Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists
    Zhang, DY
    Kohlman, D
    Krushinski, J
    Liang, S
    Ying, BP
    Reilly, JE
    Dinn, SR
    Wainscott, DB
    Nutter, S
    Gough, W
    Nelson, DLG
    Schaus, JM
    Xu, YC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) : 6011 - 6016
  • [48] CGRP Receptor Antagonism and Migraine Therapy
    Edvinsson, Lars
    Warfvinge, Karin
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2013, 14 (05) : 386 - 392
  • [49] Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine
    Durham P.L.
    Vause C.V.
    CNS Drugs, 2010, 24 (7) : 539 - 548
  • [50] CGRP antagonists in treatment of migraine attacks
    Kopka, Marcin
    AKTUALNOSCI NEUROLOGICZNE, 2018, 18 (02): : 99 - 102
12345